Osteosarcoma: Clinical Trials

4 trials for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 suspended. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Suspended 4
Phase 21Suspended 1

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
DIT309 cell injection - Osteosarcoma, Soft Tissue Sarcoma
Phase 1SuspendedTcelltech Inc.152025-11-062026-10-14
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
PEN-866, Vincristine, Temozolomide - Sarcoma, Ewing, Rhabdomyosarcoma
Phase 1 / Phase 2SuspendedNational Cancer Institute (NCI)642024-10-312026-03-16
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
NPX267 - Metastatic Malignant Neoplasm
Phase 1SuspendedNextPoint Therapeutics, Inc.1312023-07-212025-06-27
Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Recurrent Childhood Neuroblastoma, Recurrent Childhood Osteosarcoma
Phase 1SuspendedNational Cancer Institute (NCI)732022-01-252026-11-18

Narrower conditions

Sarcoma (2)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Cholangiocarcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neuroblastoma (1)  ·  Pancreatic Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Rhabdomyosarcoma (1)  ·  Sarcoma, Ewing (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Bone Tissue (4)  ·  Neoplasms, Connective Tissue (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Sarcoma (2)  ·  Adenocarcinoma (1)  ·  Breast Diseases (1)  ·  Breast Neoplasms (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)

Interventions

Biopsy (1)  ·  Cyclophosphamide (1)  ·  Specimen Handling (1)  ·  Temozolomide (1)  ·  Vincristine (1)  ·  X-Rays (1)  ·  fludarabine phosphate (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  NextPoint Therapeutics, Inc. (1)  ·  Tcelltech Inc. (1)

Countries

United States (3)  ·  China (1)

Top investigators

Christine M Heske, M.D. (1)  ·  Gangxiong Huang, MD (1)  ·  Leena Gandhi, MD, PhD (1)  ·  Rosandra N Kaplan (1)

NIH funding

U24CA224309 (1), UM1CA154967 (1), UM1CA228823 (1)